US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist
  • 1.830
  • -0.160-8.04%
Trading Apr 19 14:48 ET
45.41MMarket Cap-1115P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.09%43M
2.97%10.34M
5.66%11.2M
11.54%10.35M
12.69%11.11M
7.90%39.78M
6.98%10.04M
0.88%10.6M
16.46%9.28M
9.48%9.86M
Selling and administrative expenses
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
10.46%3.15M
-5.07%3.54M
-3.82%3.22M
-General and administrative expense
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
10.46%3.15M
-5.07%3.54M
-3.82%3.22M
Research and development costs
11.94%30.31M
-2.52%7.07M
6.43%7.93M
25.39%7.2M
22.28%8.11M
14.09%27.08M
17.28%7.25M
-2.69%7.45M
35.38%5.74M
17.37%6.64M
Operating profit
-8.09%-43M
-2.97%-10.34M
-5.66%-11.2M
-11.54%-10.35M
-12.69%-11.11M
-7.90%-39.78M
-6.98%-10.04M
-0.88%-10.6M
-16.46%-9.28M
-9.48%-9.86M
Net non-operating interest income expense
Other net income (expense)
105.55%2.67M
101.47%712K
568.50%849K
2,052.78%775K
6,860.00%338K
-688,471.43%-48.19M
-48.34M
4,133.33%127K
3,700.00%36K
-200.00%-5K
Special income (charges)
--0
----
----
----
----
---48.65M
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
--48.65M
----
----
----
----
Other non- operating income (expenses)
478.79%2.67M
134.21%712K
568.50%849K
2,052.78%775K
6,860.00%338K
6,500.00%462K
--304K
4,133.33%127K
3,700.00%36K
-200.00%-5K
Income before tax
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-138.65%-87.97M
-522.10%-58.38M
0.30%-10.47M
-15.99%-9.25M
-9.60%-9.86M
Income tax
0
0
Net income
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
Net income continuous Operations
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
Minority interest income
Net income attributable to the parent company
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
Basic earnings per share
73.38%-1.64
92.91%-0.29
52.05%-0.35
38.46%-0.4
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
-10.61%-0.73
-30.00%-0.65
-21.05%-0.69
Diluted earnings per share
73.38%-1.64
92.91%-0.29
52.05%-0.35
38.46%-0.4
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
-10.61%-0.73
-30.00%-0.65
-21.05%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.09%43M2.97%10.34M5.66%11.2M11.54%10.35M12.69%11.11M7.90%39.78M6.98%10.04M0.88%10.6M16.46%9.28M9.48%9.86M
Selling and administrative expenses -0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M-3.29%12.7M-12.89%2.79M10.46%3.15M-5.07%3.54M-3.82%3.22M
-General and administrative expense -0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M-3.29%12.7M-12.89%2.79M10.46%3.15M-5.07%3.54M-3.82%3.22M
Research and development costs 11.94%30.31M-2.52%7.07M6.43%7.93M25.39%7.2M22.28%8.11M14.09%27.08M17.28%7.25M-2.69%7.45M35.38%5.74M17.37%6.64M
Operating profit -8.09%-43M-2.97%-10.34M-5.66%-11.2M-11.54%-10.35M-12.69%-11.11M-7.90%-39.78M-6.98%-10.04M-0.88%-10.6M-16.46%-9.28M-9.48%-9.86M
Net non-operating interest income expense
Other net income (expense) 105.55%2.67M101.47%712K568.50%849K2,052.78%775K6,860.00%338K-688,471.43%-48.19M-48.34M4,133.33%127K3,700.00%36K-200.00%-5K
Special income (charges) --0-------------------48.65M----------------
-Less:Impairment of capital assets --0------------------48.65M----------------
Other non- operating income (expenses) 478.79%2.67M134.21%712K568.50%849K2,052.78%775K6,860.00%338K6,500.00%462K--304K4,133.33%127K3,700.00%36K-200.00%-5K
Income before tax 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-138.65%-87.97M-522.10%-58.38M0.30%-10.47M-15.99%-9.25M-9.60%-9.86M
Income tax 00
Net income 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M-25.23%-9.25M-16.06%-9.86M
Net income continuous Operations 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M-25.23%-9.25M-16.06%-9.86M
Minority interest income
Net income attributable to the parent company 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M-25.23%-9.25M-16.06%-9.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M-25.23%-9.25M-16.06%-9.86M
Basic earnings per share 73.38%-1.6492.91%-0.2952.05%-0.3538.46%-0.4-8.70%-0.75-164.38%-6.16-581.67%-4.09-10.61%-0.73-30.00%-0.65-21.05%-0.69
Diluted earnings per share 73.38%-1.6492.91%-0.2952.05%-0.3538.46%-0.4-8.70%-0.75-164.38%-6.16-581.67%-4.09-10.61%-0.73-30.00%-0.65-21.05%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.34%